相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML
Isabel Morgado-Palacin et al.
SCIENCE SIGNALING (2016)
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML
Isabel Morgado-Palacin et al.
SCIENCE SIGNALING (2016)
The fork and the kinase: A DNA replication tale from a CHK1 perspective
Marina A. Gonzaelez Besteiro et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
E4F1 Is a Master Regulator of CHK1-Mediated Functions
David Grote et al.
CELL REPORTS (2015)
The Transcription Factor E4F1 Coordinates CHK1-Dependent Checkpoint and Mitochondrial Functions
Genevieve Rodier et al.
CELL REPORTS (2015)
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
S. E. Fordham et al.
LEUKEMIA (2015)
ATR inhibition preferentially targets homologous recombination-deficient tumor cells
M. Krajewska et al.
ONCOGENE (2015)
CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress
L. M. Sarmento et al.
ONCOGENE (2015)
Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.
Olivier LaRochelle et al.
Oncotarget (2015)
Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia
Sarah Bertoli et al.
BLOOD (2013)
Reconciling Theory and Practice Regarding P Values
David A. Savitz
EPIDEMIOLOGY (2013)
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions
Aurelien Latouche et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
The clinical relevance of BAALC and ERG expression levels in pediatric AML
M. C. H. Hermkens et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
Judith E. Karp et al.
CLINICAL CANCER RESEARCH (2012)
Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia
Tyrone Ryba et al.
GENOME RESEARCH (2012)
An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation
Andres J. Lopez-Contreras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients
C. Allera-Moreau et al.
ONCOGENESIS (2012)
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Therapeutic Advances in Acute Myeloid Leukemia
Alan Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Carlos Santamaria et al.
ANNALS OF HEMATOLOGY (2010)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
A 'DNA replication' signature of progression and negative outcome in colorectal cancer
M-J Pillaire et al.
ONCOGENE (2010)
DNA polymerase θ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
Fanny Lemee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy
Cindy Cavelier et al.
CANCER RESEARCH (2009)
Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression
Midori Shimada et al.
CELL (2008)
ATR: an essential regulator of genome integrity
Karlene A. Cimprich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation
Rose Boutros et al.
CANCER RESEARCH (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
Upregulation of error-prone DNA polymerases β and κ slows down fork progression without activating the replication checkpoint
Marie-Jeanne Pillaire et al.
CELL CYCLE (2007)
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Jan Hellemans et al.
GENOME BIOLOGY (2007)
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics
Michael Heuser et al.
BLOOD (2006)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A
CS Sorensen et al.
CANCER CELL (2003)
分享论文
